The fact that this data is up-to-date and is generated by patients overcomes the weaknesses of traditional ADR surveillance techniques (Leaman et al., 2010).
social media could complement traditional information sources for more effective pharmacovigilance studies, as well as potentially serve as an early warning system for unknown ADR, which may be important for a clinical decision.